Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.

被引：0
|
作者：
Hammer, Liat
Rebernick, Ryan
McFarlane, Matthew
Westbrook, Thomas
Hazime, Munna
Hammoud, Tanya
Chiu, Pin-en
Xavier, Owens
Wu, Yi-Mi
Robinson, Dan R.
Spratt, Daniel Eidelberg
Alva, Ajjai Shivaram
Jackson, William C.
Reichert, Zachery R.
Alumkal, Joshi J.
Chinnaiyan, Arul
Cieslik, Marcin
Dess, Robert Timothy
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA
[3] Univ Michigan, Div Hematol & Oncol, Dept Internal Med, Ann Arbor, MI USA
[4] Univ Michigan, Canc Ctr, Ann Arbor, MI USA
[5] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[6] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[7] Michigan Med, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
263
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PHENOTYPIC-GENOTYPIC CORRELATION OF TP53 AND RB1 IN UROTHELIAL CARCINOMA
    Audenet, Francois
    Isharwal, Sumit
    Zheng, Xiaoyong
    Jordan, Emmet
    Iyer, Gopa
    Lee, Byron
    Cha, Eugene
    Donahue, Timothy
    Donat, Machele
    Herr, Harry
    Dalbagni, Guido
    Bochner, Bernard
    Berger, Michael
    Solit, David
    Al-Ahmadie, Hikmat
    JOURNAL OF UROLOGY, 2017, 197 (04): : E644 - E644
  • [32] Concurrent somatic alterations of TP53 and RB1 in Chinese lung adenocarcinoma with or without EGFR mutations.
    Wang, Jun
    Chen, Gang
    Zhang, Bicheng
    Sun, Jianguo
    Liang, Jing
    Liu, Xiaolin
    Li, Yan
    Wang, Baocheng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] The impact of TP53 mutations and use of the TP53-mutation-reactivating agent APR-246 on metastatic castrate-sensitive prostate cancer.
    Hoang, Tung
    Sutera, Philip
    Nguyen, Triet
    Chang, Jin Hee
    Jagtap, Shreya
    Song, Yang
    Shetty, Amol
    Chowdhury, Dipanwita
    Chan, Aaron
    Carrieri, Francesca Anna
    Song, Daniel Y.
    DeWeese, Theodore L.
    Lafargue, Audrey
    Van der Eecken, Kim
    Ost, Fred Bunz Piet
    Tran, Phuoc T.
    Deek, Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Genetic Variations in TP53, RB1, and PTEN in a Selected Sample of Slovak Patients With Metastatic Castration-resistant Prostate Cancer
    Holeckova, Klaudia Hives
    Hives, Mark
    Grendar, Marian
    Drobkova, Henrieta Blahusiak
    Kliment, Jan, Sr.
    IN VIVO, 2024, 38 (06): : 2610 - 2616
  • [35] Impact of TP53 mutations in Triple Negative Breast Cancer
    Zahi I. Mitri
    Nour Abuhadra
    Shaun M. Goodyear
    Evthokia A. Hobbs
    Andy Kaempf
    Alastair M. Thompson
    Stacy L. Moulder
    npj Precision Oncology, 6
  • [36] Impact of TP53 mutations in Triple Negative Breast Cancer
    Mitri, Zahi, I
    Abuhadra, Nour
    Goodyear, Shaun M.
    Hobbs, Evthokia A.
    Kaempf, Andy
    Thompson, Alastair M.
    Moulder, Stacy L.
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [37] Biallelic loss of TP53, PTEN, and RB1 in association to aggressive clinical features and poor outcomes in metastatic castration-resistant prostate cancer (mCRPC).
    Maurice-Dror, Corinne
    Fonseca, Nicolette
    Herberts, Cameron
    Kwan, Edmond Michael
    Kollmannsberger, Catarina
    Tu, Wilson
    Khalaf, Daniel Joseph
    Annala, Matti
    Schonlau, Elena
    Bernales, Cecily Q.
    Donnellan, Grainne
    Vergidis, Joanna
    Noonan, Krista
    Finch, Daygen L.
    Zulfiqar, Muhammad
    Stacy, Miller
    Wyatt, Alexander William
    Chi, Kim N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Clinical implications of germline mutations in breast cancer: TP53
    Katherine Schon
    Marc Tischkowitz
    Breast Cancer Research and Treatment, 2018, 167 : 417 - 423
  • [39] Clinical implications of germline mutations in breast cancer: TP53
    Schon, Katherine
    Tischkowitz, Marc
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 417 - 423
  • [40] Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer
    Sheng, Shuyan
    Xu, Ye
    Guo, Yonghai
    Yao, Lu
    Hu, Li
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (02) : 487 - 495
12345